118 related articles for article (PubMed ID: 18471157)
1. Comedication of caspofungin acetate and cyclosporine A after allogeneic haematopoietic stem cell transplantation leads to negligible hepatotoxicity.
Christopeit M; Eikam M; Behre G
Mycoses; 2008; 51 Suppl 1():19-24. PubMed ID: 18471157
[TBL] [Abstract][Full Text] [Related]
2. Retrospective study of the hepatic safety profile of patients concomitantly treated with caspofungin and cyclosporin A.
Marr KA; Hachem R; Papanicolaou G; Somani J; Arduino JM; Lipka CJ; Ngai AL; Kartsonis N; Chodakewitz J; Sable C
Transpl Infect Dis; 2004 Sep; 6(3):110-6. PubMed ID: 15569226
[TBL] [Abstract][Full Text] [Related]
3. Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients.
Chou LS; Lewis RE; Ippoliti C; Champlin RE; Kontoyiannis DP
Pharmacotherapy; 2007 Dec; 27(12):1644-50. PubMed ID: 18041885
[TBL] [Abstract][Full Text] [Related]
4. [Caspofungin after solid organ transplantation in Germany: observational study on treatment of invasive fungal infections].
Lichtenstern C; Pratschke J; Schulz U; Schmoeckel M; Knitsch W; Kaskel P; Krobot KJ; Weigand MA; Winkler M
Anaesthesist; 2010 Dec; 59(12):1083-90. PubMed ID: 21069271
[TBL] [Abstract][Full Text] [Related]
5. Safety profile of concomitant use of caspofungin and cyclosporine or tacrolimus in liver transplant patients.
Saner F; Gensicke J; Rath P; Fruhauf N; Gu Y; Paul A; Radtke A; Malagó M; Broelsch C
Infection; 2006 Dec; 34(6):328-32. PubMed ID: 17180587
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: a retrospective, observational, sequential cohort analysis.
Kubiak DW; Bryar JM; McDonnell AM; Delgado-Flores JO; Mui E; Baden LR; Marty FM
Clin Ther; 2010 Apr; 32(4):637-48. PubMed ID: 20435233
[TBL] [Abstract][Full Text] [Related]
7. Caspofungin as antifungal prophylaxis in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis.
Döring M; Hartmann U; Erbacher A; Lang P; Handgretinger R; Müller I
BMC Infect Dis; 2012 Jul; 12():151. PubMed ID: 22747637
[TBL] [Abstract][Full Text] [Related]
8. Caspofungin as first-line therapy for the treatment of invasive aspergillosis after thoracic organ transplantation.
Groetzner J; Kaczmarek I; Wittwer T; Strauch J; Meiser B; Wahlers T; Daebritz S; Reichart B
J Heart Lung Transplant; 2008 Jan; 27(1):1-6. PubMed ID: 18187079
[TBL] [Abstract][Full Text] [Related]
9. Safety of anidulafungin in solid organ transplant recipients.
Aguado JM; Varo E; Usetti P; Pozo JC; Moreno A; Catalán M; Len O; Blanes M; Solé A; Muñoz P; Montejo M;
Liver Transpl; 2012 Jun; 18(6):680-5. PubMed ID: 22328277
[TBL] [Abstract][Full Text] [Related]
10. [Tolerance of caspofungin in intensive care unit: a prospective study].
Constantin JM; Roszyk L; Guerin R; Bannier F; Chartier C; Perbet S; Futier E; Cayot-Constantin S; Sapin V; Bazin JE
Ann Fr Anesth Reanim; 2008 Oct; 27(10):819-24. PubMed ID: 18835682
[TBL] [Abstract][Full Text] [Related]
11. Randomized comparison of safety and pharmacokinetics of caspofungin, liposomal amphotericin B, and the combination of both in allogeneic hematopoietic stem cell recipients.
Groll AH; Silling G; Young C; Schwerdtfeger R; Ostermann H; Heinz WJ; Gerss J; Kolve H; Lanvers-Kaminsky C; Vieira Pinheiro JP; Gammelin S; Cornely OA; Wuerthwein G
Antimicrob Agents Chemother; 2010 Oct; 54(10):4143-9. PubMed ID: 20660670
[TBL] [Abstract][Full Text] [Related]
12. Caspofungin treatment in severely ill, immunocompromised patients: a case-documentation study of 118 patients.
Glasmacher A; Cornely OA; Orlopp K; Reuter S; Blaschke S; Eichel M; Silling G; Simons B; Egerer G; Siemann M; Florek M; Schnitzler R; Ebeling P; Ritter J; Reinel H; Schütt P; Fischer H; Hahn C; Just-Nuebling G
J Antimicrob Chemother; 2006 Jan; 57(1):127-34. PubMed ID: 16308418
[TBL] [Abstract][Full Text] [Related]
13. Retrospective evaluation of caspofungin therapy in invasive aspergillosis (RECAM-IA).
Wisniewski T; Klimko N; Laverdiere M; Kiertiburanakul S; Kliasova G; Trenschel R; Kumar RN
Mycoses; 2011 Jul; 54(4):e148-53. PubMed ID: 20202110
[TBL] [Abstract][Full Text] [Related]
14. Drug interactions and safety profiles with concomitant use of caspofungin and calcineurin inhibitors in allogeneic haematopoietic cell transplantation.
Nishimoto M; Koh H; Tokuwame A; Makuuchi Y; Kuno M; Takakuwa T; Okamura H; Koh S; Yoshimura T; Nanno S; Nakamae M; Hirose A; Nakashima Y; Nakane T; Hino M; Nakamae H
Br J Clin Pharmacol; 2017 Sep; 83(9):2000-2007. PubMed ID: 28407449
[TBL] [Abstract][Full Text] [Related]
15. Caspofungin in the treatment of azole-refractory esophageal candidiasis in kidney transplant recipients.
Veroux M; Macarone M; Fiamingo P; Cappello D; Gagliano M; Di Mare M; Vizcarra D; Spataro M; Giuffrida G; Sorbello M; Severino V; Veroux P
Transplant Proc; 2006 May; 38(4):1037-9. PubMed ID: 16757256
[TBL] [Abstract][Full Text] [Related]
16. Experiences with the use of caspofungin in paediatric patients.
Lehrnbecher T; Groll AH
Mycoses; 2008; 51 Suppl 1():58-64. PubMed ID: 18471162
[TBL] [Abstract][Full Text] [Related]
17. Empirical caspofungin therapy in clinical practice for suspected invasive fungal disease in adults with acute lymphoblastic leukaemia.
Kiehl MG; Egerer G; Engelhardt M; Gross B
Mycoses; 2015 Feb; 58(2):76-81. PubMed ID: 25590660
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of caspofungin for the empiric management of fever in neutropenic children.
Koo A; Sung L; Allen U; Naqvi A; Drynan-Arsenault J; Dekker A; Maloney AM; Dupuis LL
Pediatr Infect Dis J; 2007 Sep; 26(9):854-6. PubMed ID: 17721388
[TBL] [Abstract][Full Text] [Related]
19. An early CT-diagnosis-based treatment strategy for invasive fungal infection in allogeneic transplant recipients using caspofungin first line: an effective strategy with low mortality.
Dignan FL; Evans SO; Ethell ME; Shaw BE; Davies FE; Dearden CE; Treleaven JG; Riley UB; Morgan GJ; Potter MN
Bone Marrow Transplant; 2009 Jul; 44(1):51-6. PubMed ID: 19139735
[TBL] [Abstract][Full Text] [Related]
20. Caspofungin as salvage monotherapy for invasive aspergillosis in patients with haematological malignancies or following allogeneic stem cell transplantation: efficacy and concomitant cyclosporin A.
Morrissey CO; Slavin MA; O'Reilly MA; Daffy JR; Seymour JF; Schwarer AP; Szer J
Mycoses; 2007; 50 Suppl 1():24-37. PubMed ID: 17394607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
